Soft tissue regeneration company Aroa, with Wilsons acting as Joint Lead Manager and Joint Underwriter, recently completed a $45 million initial public offering (IPO), positioning the business to capitalise on its leading technology and market opportunity.
23rd Aug, 2020
Wilsons acted as Sole Lead Manager and Underwriter to Nuchev Limited’s (NUC:ASX) recent entitlement offer and institutional placement to raise $15.2m.
22nd Aug, 2020
The proportion of market earnings sourced offshore for Australian companies has risen in recent years, with around 25% of the S&P/ASX 100 earnings – ex-resources – exposed to offshore earnings.
20th Aug, 2020
While the A$ at its current level of 71-72c is moving toward the fair value zone, we still see some potential upside into the 75-80c area over the next year or so and are retaining our hedge for now.
17th Aug, 2020
We are around one-third of the way into the reporting season. The key theme emerging at this point is that COVID-19 has had a significant, but uneven impact on all businesses.
13th Aug, 2020
Prior to the COVID-19 crisis, inflation was viewed as a tail risk with a very low probability. However, with the implementation of extreme fiscal and monetary stimulus across the globe, the risk of inflation re-accelerating at some point should be a consideration in structuring well-diversified portfolios.
10th Aug, 2020
For the first time in almost 30 years the August reporting season for the Australian market is occurring against the unusual backdrop of both the domestic and global economies being in a recession.
6th Aug, 2020
This month we add Appen (APX) to Conviction Insights, a global leader in the collection, labelling and analysis of data used to build and continuously improve some of the world’s most innovative artificial intelligence and search systems.
4th Aug, 2020